The private equity owners of Stada are close to mandating investment banks to sell the German generic drugmaker or list it on the stock exchange, newspaper Handelsblatt reported on Wednesday, citing financial sources.
The company, majority-owned (since 2017) by buyout firms Bain and Cinven, who you can meet at the UK Private Equity Conference, sells consumer healthcare products such as painkillers and sunscreen lotions, as well as biosimilar and generic drugs, which are cheaper copies of established pharmaceuticals that have lost patent protection.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Stada declined to comment. A spokesperson for Cinven could not immediately be reached for comment.
The Handelsblatt report said the most likely option for now was the sale of a minority stake in Stada to a third investor, and said Stada could be valued at up to 15bn euros ($16.10 bn) in a transaction.
Source: Yahoo! Finance
Can’t stop reading? Read more
EQT leads $5.5bn Galderma share sale in record Swiss secondary exit
EQT leads $5.5bn Galderma share sale in record Swiss secondary exit EQT and its co-investors have...
CVC reports record performance as €205bn private markets platform expands
CVC reports record performance as €205bn private markets platform expands CVC Capital Partners...
Brookfield explores $1.3bn acquisition of EQT and PAI-backed World Freight Company
Brookfield explores $1.3bn acquisition of EQT and PAI-backed World Freight Company Brookfield...